Merck’s Q3 earnings beat estimates, but company lowers guidance

• Pfizer’s earnings crush estimates as company raises guidance

  Business - MarketWatch - Yesterday

• Biogen’s stock hit by soft sales of Alzheimer’s treatment

  Business - MarketWatch - 21 hours ago

• Bristol Myers’s stock pops as earnings top estimates and company raises guidance

  Business - MarketWatch - 1 hour ago

• Harley-Davidson’s stock falls as motorbike maker lowers guidance to reflect still-pressured consumer

  Business - MarketWatch - 6 days ago

• Reddit’s stock soars after social-media platform turns a profit, beats Q3 sales and earnings estimates

  Business - MarketWatch - Yesterday

• Centene’s stock soars 11% after earnings sweep past estimates and company backs guidance

  Business - MarketWatch - 5 days ago

• Comcast tops earnings estimates as Olympics propel the company

  Business - CNBC - 18 minutes ago

More from MarketWatch

• ‘I have the father-in-law from hell’: He stole my late husband’s savings — and took ownership of our home. What can I do?

  Business - MarketWatch - 5 minutes ago

• MicroStrategy’s Saylor on the strategy to load up on bitcoin and how investors should value it

  Business - MarketWatch - 21 minutes ago

• Roblox’s stock soars on third-quarter bookings beat and raised guidance

  Business - MarketWatch - 22 minutes ago

• Why Microsoft’s stock selloff may be a buying opportunity, according to analysts

  Business - MarketWatch - 32 minutes ago

• Harris improves her odds over Trump, according to these economic indicators

  Business - MarketWatch - 34 minutes ago